| 2017 | | Response to Dr Giannini et al | 김순선, 정재연, 조성원, 조효정 |
| 2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
| 2016 | | Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B | 김순선, 임영애, 정재연, 조성원 |
| 2016 | | Endoscopic Hands-Off Technique versus Conventional Technique for Conversion from an Orobiliary to a Nasobiliary Tube | 김순선, 김진홍, 노충균, 양민재, 유병무, 황재철 |
| 2016 | | The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use | 강준구, 김순선, 김진홍, 박래웅, 신성재, 윤덕용, 이기명, 임선교, 황재철 |
| 2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2016 | | Endoscopic naso-gallbladder drainage versus gallbladder stenting before cholecystectomy in patients with acute cholecystitis and a high suspicion of choledocholithiasis: a prospective randomised preliminary study | 김순선, 김욱환, 김지훈, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
| 2016 | | Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B | 김순선, 박주한, 정재연, 조성원, 조효정 |
| 2015 | | Wire-guided cannulation over a pancreatic stent versus double guidewire technique in patients with difficult biliary cannulation. | 강준구, 김순선, 김진홍, 류형규, 양민재, 유병무, 황재철 |
| 2015 | | Endoscopic ultrasound-guided sampling of solid pancreatic masses: 22-gauge aspiration versus 25-gauge biopsy needles. | 강준구, 김순선, 김영배, 김진홍, 양민재, 유병무, 이다근, 임선교, 임현이, 황재철 |
| 2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
| 2015 | | Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance. | 김순선, 신성재, 유병무, 정재연, 조성원, 조효정 |
| 2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2014 | | Embolization of percutaneous transhepatic portal venous access tract with N-butyl cyanoacrylate. | 김봉완, 김순선, 김진우, 왕희정, 원제환, 정재연, 조성원 |
